Condition

Relapsed/Refractory Autoimmune Hemolytic Anemia

ClinicalTrials.gov condition label

Clinical trials1

Recruiting1

Common interventions1

Lead sponsors shown1

Clinical trials

1 shown

Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune DiseasesNCT07361094 · 2025-11-06

RECRUITING

Common interventions

Autologous CD19-BCMA Dual-Target CAR T-Cell TherapyDRUG1

Leading sponsors

Beijing Boren Hospital1

Trial status mix

RECRUITING1

Phase mix

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.